Assist
Where required, assists with the provision of analytical services, also ensures that proper disposal requirements are prescribed for the safe disposal of cannabis which is handled under the Act.
Learn MoreThe Content of this website is for MATURE audiences only.
By continuing to view the website you are claiming that you are 18 years or older.
Call: +1 (246) 421-4141 | Email: clo@bmcla.bb
Where required, assists with the provision of analytical services, also ensures that proper disposal requirements are prescribed for the safe disposal of cannabis which is handled under the Act.
Learn MoreDevelop policies, procedures and guidelines to establish the medicinal cannabis industry and to ensure that medicinal cannabis is available to patients in a safe and efficient manner.
Learn MoreIssues licences in relation to the handling of medicinal cannabis in accordance with the provisions of the Act, 2019, also provides for the distribution of educational materials etc.
Learn MoreRegulates the handling of medicinal cannabis, with the approval of the Barbados Medicinal Cannabis Licensing Board, establishes and maintains an electronic database.
Learn MoreEveryone's response to cannabis differs and can vary from one time to the next.
Like any other drug, cannabis can:
[1] [2] [3] World Health Organization (WHO). The health and social effects of nonmedical cannabis use.
The BMCLA can suspend or revoke a license where:
the person issued the license is convicted of an offence under the Act;
the person issued with the license contravenes a term of condition of the license granted under the Act.
the Minister requires the suspension or revocation of the license in the interest of public health or public safety.
For more about the Barbados Medicinal Industry Act please click here
A pharmacist or authorized personnel in a pharmacy or a therapeutic facility may dispense medicinal cannabis to a patient and where applicable, to a caregiver for a patient. A pharmacist or authorized personnel in a pharmacy should only dispense medicinal cannabis on the submission by a patient, or where applicable, a caregiver, of a prescription and a valid form of identification for the patient. Upon dispensing medicinal cannabis to a patient or, where applicable, a caregiver, a pharmacist should ensure that the label given in respect of the prescription has the information required by regulations of the Pharmacy (compounding and Dispensing of Drugs and Poisons) Regulations, 1986. A pharmacist shall enter the information of the patient in a register kept by him or her and established for the purpose, in the prescribed manner:
Conform to any requirement or limitation set by the medical practitioner as to the form of medicinal cannabis that is required in relation to the patient;
Provide to a patient and where applicable, a caregiver, information on the lawful methods for administering medicinal cannabis in individual doses;
Provide to a patient and where applicable, a caregiver, information on how to prevent or deter the misuse of medicinal cannabis by a minor; or
Provide to a patient, and where applicable, a caregiver, any other information which the pharmacist may consider to be relevant.
Cannabinoids are chemicals which interact with the endocannabinoid system in mammals. These can be found in the Cannabis plant (phytocannabinoids), endogenously derived (endocannabinoids) or synthesised chemically. Research has found that the cannabis plant produces approximately 120 cannabinoids and about 300 non-cannabinoid chemicals. The two main clinically relevant cannabinoids are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). The most commonly known of the two is delta-9-tetrahydrocannabinol (THC), which is the chemical that is primarily responsible for the psychoactive effects of cannabis.
There are two major concerns regarding smoking medicinal cannabis.
Firstly, smoking is a particularly harmful way of taking medicinal cannabis, mainly because it poses comparable risks for bronchitis and lung cancer, as is the smoking of cigarettes. Smoking medicinal cannabis is not permitted by local or international Health authorities.
Secondly, approved medicines used in Barbados are produced under strict conditions to ensure efficacy and safety. It is important that medical doctors know that medicines have been tested and are standardized by dose and therapeutic response. This means doctors can monitor the effects of the drug and doses can be adjusted according to a patient’s needs.
It is understood that smoked cannabis will not be prescribed in Barbados because smoked plant products will not satisfy governmental requirements.
A person designated as a caregiver under this Act shall obtain from a medical practitioner a certificate that states that the caregiver is not dependent on a controlled drug.